Who founded LIPAC Oncology?

LIPAC Oncology was founded by Ramachandran "TR" Thirucote, Michael Oefelein in 2016.

How much funding has LIPAC Oncology raised?

LIPAC Oncology has disclosed $372.5K raised across 1 round.

Where is LIPAC Oncology headquartered?

LIPAC Oncology is headquartered in Pomona, US.

LIPAC Oncology

Pomona, US · Founded 2016 · Delaware LLC

LIPAC Oncology is a pharmaceutical company developing chemotherapy treatments based on LiPax, a neoliposomal platform for local, targeted delivery of paclitaxel to treat intracavitary carcinomas. Its lead program targets non-muscle invasive bladder cancer, with additional indications in thoracic, upper tract urothelial, peritoneal, and ovarian cancers.

Biotech Healthtech Medical Devices

Founders & leadership

LIPAC Oncology was founded in 2016 by Ramachandran "TR" Thirucote and Michael Oefelein.

Ramachandran "TR" ThirucoteFounding Chairman & Chief Executive Officer

Michael OefeleinCo-founder & Chief Medical Officer

Willem A RobbertsNamed on SEC filing

Thirucote RamachandranNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$372.5K disclosed across 1 round · 2020

▶$372.5KraisedJul 2020 · 6 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Willem A RobbertsExecutive Officer, Director
Thirucote RamachandranExecutive Officer, Director

Offering amount: $5M
Amount sold: $372.5K
First sale: Jan 2020
Incorporated: Limited Liability Company, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Cancerresearchuk11 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.

Companies competing with LIPAC Oncology for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does LIPAC Oncology do?: LIPAC Oncology is a pharmaceutical company developing chemotherapy treatments based on LiPax, a neoliposomal platform for local, targeted delivery of paclitaxel to treat intracavitary carcinomas. Its lead program targets non-muscle invasive bladder cancer, with additional indications in thoracic, upper tract urothelial, peritoneal, and ovarian cancers.
Who founded LIPAC Oncology?: LIPAC Oncology was founded by Ramachandran "TR" Thirucote, Michael Oefelein in 2016.
How much funding has LIPAC Oncology raised?: LIPAC Oncology has disclosed $372.5K raised across 1 round.
Where is LIPAC Oncology headquartered?: LIPAC Oncology is headquartered in Pomona, US.